Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MBX Biosciences (MBX) Prepaid Assets (2023 - 2026)

MBX Biosciences has reported Prepaid Assets over the past 4 years, most recently at $8.6 million for Q1 2026.

  • Quarterly results put Prepaid Assets at $8.6 million for Q1 2026, up 1267.25% from a year ago — trailing twelve months through Mar 2026 was $8.6 million (up 1267.25% YoY), and the annual figure for FY2025 was $7.8 million, up 52.5%.
  • Prepaid Assets reached $8.6 million in Q1 2026 per MBX's latest filing, up from $7.8 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $8.6 million in Q1 2026 and bottomed at $133000.0 in Q4 2023.
  • Median Prepaid Assets over the past 4 years was $860000.0 (2024), compared with a mean of $3.1 million.
  • The largest annual shift saw Prepaid Assets soared 3762.41% in 2024 before it increased 5.25% in 2025.
  • Over 4 years, Prepaid Assets stood at $133000.0 in 2023, then skyrocketed by 3762.41% to $5.1 million in 2024, then soared by 52.5% to $7.8 million in 2025, then grew by 9.25% to $8.6 million in 2026.
  • Business Quant data shows Prepaid Assets for MBX at $8.6 million in Q1 2026, $7.8 million in Q4 2025, and $882000.0 in Q3 2025.